Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP208638.RAXs7fndQkKJqReeb-ivcS-qHthwCt-CzvbbTJ_cVRY4M130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208638.RAXs7fndQkKJqReeb-ivcS-qHthwCt-CzvbbTJ_cVRY4M130_provenance.
• NP535873.RAq_FqXYqO_RzCb-M5Nmm_tUZUEnenZ_zgGxj7IHXOyig130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP535873.RAq_FqXYqO_RzCb-M5Nmm_tUZUEnenZ_zgGxj7IHXOyig130_provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP406826.RARX0fhKYMYpMZLAmpkuJa2e2Cqrti6N0v1f-2gYexWkA130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP406826.RARX0fhKYMYpMZLAmpkuJa2e2Cqrti6N0v1f-2gYexWkA130_provenance.
• NP761036.RA0KOjoR1RTbCmIHS0ITBigIRWf8-od_O9BAEJDWgeU7E130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP761036.RA0KOjoR1RTbCmIHS0ITBigIRWf8-od_O9BAEJDWgeU7E130_provenance.
• NP411705.RAIqd1hYn1OrtBLyO9Vvu2QJqV270MGzh5o1hWPuhOw54130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411705.RAIqd1hYn1OrtBLyO9Vvu2QJqV270MGzh5o1hWPuhOw54130_provenance.
• NP689724.RAB1VDk5f-NMkBJrPEBdIfKvv91hXqhV2AK-3BZfz-s_E130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689724.RAB1VDk5f-NMkBJrPEBdIfKvv91hXqhV2AK-3BZfz-s_E130_provenance.
• NP689727.RAAD-GmdwfCtxHBQEL3XQVCVpf6kssBho29JepL2DeqwQ130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689727.RAAD-GmdwfCtxHBQEL3XQVCVpf6kssBho29JepL2DeqwQ130_provenance.
• NP559274.RAQgE6ObpBM92_S9IW4aqCabiu-d6Lp4F499xhbrUeGSc130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559274.RAQgE6ObpBM92_S9IW4aqCabiu-d6Lp4F499xhbrUeGSc130_provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP219521.RAIHzVQd7kyypAkbrgN4HYn0XSSwgdB24mb4uhgtCMVuQ130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219521.RAIHzVQd7kyypAkbrgN4HYn0XSSwgdB24mb4uhgtCMVuQ130_provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP558908.RAKlcRfo_o-OSy-LX5L1DxWtQiHx28mJ-lIg43ts6HaXQ130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP558908.RAKlcRfo_o-OSy-LX5L1DxWtQiHx28mJ-lIg43ts6HaXQ130_provenance.
• NP689725.RAM6IgTdV6ehTF0cRiUL0DuzjjwPg3_dKapsM0KDfP6m4130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689725.RAM6IgTdV6ehTF0cRiUL0DuzjjwPg3_dKapsM0KDfP6m4130_provenance.
• NP689726.RAJ90vAT0otxVjUinTOyDDka5WaKNmIKPFYMEGwfrBTfE130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689726.RAJ90vAT0otxVjUinTOyDDka5WaKNmIKPFYMEGwfrBTfE130_provenance.
• NP689729.RAFNtOlP-uY9rir-Qv5Fd91DZCGoInI4-1DuH9tOITLFw130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689729.RAFNtOlP-uY9rir-Qv5Fd91DZCGoInI4-1DuH9tOITLFw130_provenance.
• NP689728.RAgVgTwicFkm26_ssjNqZwO3MECcoK2Ibc8WptaJqkQ8U130_assertion description "[In acute lymphoblastic leukemia, besides age and white cell count at diagnosis, the cytogenetic abnormalities t(9;22)/BCR-ABL and t(4;11)/MLL-AF4 are important prognostic markers and are often included in the treatment stratification of patients with adult acute lymphoblastic leukemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689728.RAgVgTwicFkm26_ssjNqZwO3MECcoK2Ibc8WptaJqkQ8U130_provenance.